Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 24286239)

1.

Sex differences in the treatment and outcome of patients with acute coronary syndrome after percutaneous coronary intervention: a population-based study.

Lin CF, Shen LJ, Hsiao FY, Gau CS, Wu FL.

J Womens Health (Larchmt). 2014 Mar;23(3):238-45. doi: 10.1089/jwh.2013.4474. Epub 2013 Nov 28.

2.

Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.

Lin CF, Shen LJ, Wu FL, Bai CH, Gau CS.

Br J Clin Pharmacol. 2012 Nov;74(5):824-34. doi: 10.1111/j.1365-2125.2012.04250.x.

4.

Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome.

Chen SC, Hsiao FY, Lee CM, Hsu WW, Gau CS.

BMC Cardiovasc Disord. 2014 Feb 18;14:21. doi: 10.1186/1471-2261-14-21.

5.

Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).

Ojeifo O, Wiviott SD, Antman EM, Murphy SA, Udell JA, Bates ER, Mega JL, Sabatine MS, O'Donoghue ML.

JACC Cardiovasc Interv. 2013 Dec;6(12):1275-81. doi: 10.1016/j.jcin.2013.06.014. Epub 2013 Nov 13.

6.

Impact of ezetimibe coadministered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in Taiwan.

Lin CF, Gau CS, Wu FL, Hsiao FY, Bai CH, Shen LJ.

Clin Ther. 2011 Sep;33(9):1120-31. doi: 10.1016/j.clinthera.2011.08.002. Epub 2011 Aug 27.

PMID:
21872930
7.

The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis.

Rogowski W, Burch J, Palmer S, Craigs C, Golder S, Woolacott N.

Health Technol Assess. 2009 Jun;13(31):iii-iv, ix-xi, 1-77. doi: 10.3310/hta13310. Review.

8.

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS.

JAMA. 2009 Mar 4;301(9):937-44. doi: 10.1001/jama.2009.261.

PMID:
19258584
9.

Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis.

Meadows ES, Bae JP, Zagar A, Sugihara T, Ramaswamy K, McCracken R, Heiselman D.

BMC Res Notes. 2012 Jul 2;5:342. doi: 10.1186/1756-0500-5-342.

10.

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome.

Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, Jesse RA, Rumsfeld JS.

JAMA. 2008 Feb 6;299(5):532-9. doi: 10.1001/jama.299.5.532. Erratum in: JAMA. 2008 May 28;299(20):2390.

PMID:
18252883
12.

Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.

Hsiao FY, Mullins CD, Wen YW, Huang WF, Chen PF, Tsai YW.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1043-9. doi: 10.1002/pds.2202. Epub 2011 Aug 8.

PMID:
21823195
13.

Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention.

Ardati AK, Pitt B, Smith DE, Aronow HD, Share D, Moscucci M, Chetcuti S, Grossman PM, Gurm HS.

Am Heart J. 2013 May;165(5):778-84. doi: 10.1016/j.ahj.2013.01.015. Epub 2013 Feb 19.

PMID:
23622915
14.

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation.

JAMA. 2002 Nov 20;288(19):2411-20. Erratum in: JAMA. 2003 Feb 26;289(8):987..

PMID:
12435254
16.

Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.

Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.

Thromb Haemost. 2010 Dec;104(6):1211-8. doi: 10.1160/TH10-04-0218. Epub 2010 Oct 12.

PMID:
20941464
17.

Efficacy of cilostazol in patients with acute coronary syndrome after percutaneous coronary intervention.

Hu T, Ma H, Li H, Ren J.

Am J Ther. 2013 Mar-Apr;20(2):151-3. doi: 10.1097/MJT.0b013e31825a3616.

PMID:
22975664
18.

High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.

Parodi G, Marcucci R, Valenti R, Gori AM, Migliorini A, Giusti B, Buonamici P, Gensini GF, Abbate R, Antoniucci D.

JAMA. 2011 Sep 21;306(11):1215-23. doi: 10.1001/jama.2011.1332.

PMID:
21934054
19.

Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndromes.

El-Menyar A, AlHabib KF, Al-Motarreb A, Hersi A, Al Faleh H, Asaad N, Al Saif S, Almahmeed W, Sulaiman K, Amin H, Al-Lawati J, Alsheikh-Ali AA, AlQahtani A, Al-Sagheer NQ, Singh R, Al Suwaidi J.

Am J Cardiovasc Drugs. 2012 Apr 1;12(2):127-35. doi: 10.2165/11597580-000000000-00000.

PMID:
22257172
20.

Differential prognostic impact of high on-treatment platelet reactivity among patients with acute coronary syndromes versus stable coronary artery disease undergoing percutaneous coronary intervention.

Park DW, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ, Yun SC, Lee SW, Kim YH, Lee CW, Park SW, Park SJ.

Am Heart J. 2013 Jan;165(1):34-42.e1. doi: 10.1016/j.ahj.2012.10.013. Epub 2012 Nov 17.

PMID:
23237131
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk